These results indicated that 6MW3211 could effectively restore the phagocytosis of CD47-expressing cancer cells by blocking the inhibitory signal triggered by the interaction between mSIRPα expressed on mouse macrophages and hCD47 expressed on tumor cells. Here, CD47 is linked to neoplasm.